These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 17504892

  • 21. Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome.
    Morin-Papunen L, Rautio K, Ruokonen A, Hedberg P, Puukka M, Tapanainen JS.
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4649-54. PubMed ID: 14557435
    [Abstract] [Full Text] [Related]

  • 22. Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.
    Moradi S, Mollabashi M, Kerman SR.
    Gynecol Endocrinol; 2011 Jul; 27(7):480-5. PubMed ID: 20836727
    [Abstract] [Full Text] [Related]

  • 23. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 24. The effect of bariatric surgery on inflammatory markers in women with polycystic ovarian syndrome.
    Abiad F, Khalife D, Safadi B, Alami R, Awwad J, Khalifeh F, Ghazeeri G.
    Diabetes Metab Syndr; 2018 Nov; 12(6):999-1005. PubMed ID: 30168430
    [Abstract] [Full Text] [Related]

  • 25. Dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility.
    Tsai YH, Wang TW, Wei HJ, Hsu CY, Ho HJ, Chen WH, Young R, Liaw CM, Chao JC.
    Br J Nutr; 2013 Jun 28; 109(12):2190-8. PubMed ID: 23046530
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.
    Glintborg D, Andersen M, Hagen C, Frystyk J, Hulstrøm V, Flyvbjerg A, Hermann AP.
    Eur J Endocrinol; 2006 Aug 28; 155(2):337-45. PubMed ID: 16868149
    [Abstract] [Full Text] [Related]

  • 27. [Correlations between adipocytokines and insulin resistance in women with polycystic ovary syndrome].
    Li X, Li X, Huang HY, Ma D, Zhu MW, Lin JF.
    Zhonghua Yi Xue Za Zhi; 2009 Oct 13; 89(37):2607-10. PubMed ID: 20137676
    [Abstract] [Full Text] [Related]

  • 28. Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease.
    Boulman N, Levy Y, Leiba R, Shachar S, Linn R, Zinder O, Blumenfeld Z.
    J Clin Endocrinol Metab; 2004 May 13; 89(5):2160-5. PubMed ID: 15126536
    [Abstract] [Full Text] [Related]

  • 29. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance.
    O'Connor A, Phelan N, Tun TK, Boran G, Gibney J, Roche HM.
    J Clin Endocrinol Metab; 2010 Mar 13; 95(3):1378-85. PubMed ID: 20080859
    [Abstract] [Full Text] [Related]

  • 30. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome.
    Faloia E, Canibus P, Gatti C, Frezza F, Santangelo M, Garrapa GG, Boscaro M.
    J Endocrinol Invest; 2004 May 13; 27(5):424-9. PubMed ID: 15279073
    [Abstract] [Full Text] [Related]

  • 31. Early metabolic derangements in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T, Maliqueo M, Codner E, Echiburú B, Crisosto N, Pérez V, Pérez-Bravo F, Cassorla F.
    J Clin Endocrinol Metab; 2007 Dec 13; 92(12):4637-42. PubMed ID: 17848407
    [Abstract] [Full Text] [Related]

  • 32. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E, Coulson R, Dunstan F, Evans WD, Blundell HL, Luzio SD, Dunseath G, Halcox JP, Fraser AG, Rees DA.
    Hum Reprod; 2014 Sep 13; 29(9):2041-9. PubMed ID: 25035436
    [Abstract] [Full Text] [Related]

  • 33. Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome.
    El-Mesallamy HO, Abd El-Razek RS, El-Refaie TA.
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun 13; 168(2):178-82. PubMed ID: 23434327
    [Abstract] [Full Text] [Related]

  • 34. Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance.
    Bahceci M, Tuzcu A, Canoruc N, Tuzun Y, Kidir V, Aslan C.
    Horm Res; 2004 Jun 13; 62(6):283-7. PubMed ID: 15542929
    [Abstract] [Full Text] [Related]

  • 35. 17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss.
    Jakubowicz DJ, Nestler JE.
    J Clin Endocrinol Metab; 1997 Feb 13; 82(2):556-60. PubMed ID: 9024253
    [Abstract] [Full Text] [Related]

  • 36. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF.
    Arch Gynecol Obstet; 2010 Jun 13; 281(6):1009-14. PubMed ID: 19771438
    [Abstract] [Full Text] [Related]

  • 37. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.
    Holte J, Bergh T, Berne C, Wide L, Lithell H.
    J Clin Endocrinol Metab; 1995 Sep 13; 80(9):2586-93. PubMed ID: 7673399
    [Abstract] [Full Text] [Related]

  • 38. Follistatin and activins in polycystic ovary syndrome: relationship to metabolic and hormonal markers.
    Teede H, Ng S, Hedger M, Moran L.
    Metabolism; 2013 Oct 13; 62(10):1394-400. PubMed ID: 23768911
    [Abstract] [Full Text] [Related]

  • 39. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
    Paradisi G, Steinberg HO, Shepard MK, Hook G, Baron AD.
    J Clin Endocrinol Metab; 2003 Feb 13; 88(2):576-80. PubMed ID: 12574183
    [Abstract] [Full Text] [Related]

  • 40. The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers.
    Xita N, Papassotiriou I, Georgiou I, Vounatsou M, Margeli A, Tsatsoulis A.
    Metabolism; 2007 Jun 13; 56(6):766-71. PubMed ID: 17512308
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.